210 related articles for article (PubMed ID: 36389163)
1. Infections of
Kitisin T; Muangkaew W; Sukphopetch P
Front Cell Infect Microbiol; 2022; 12():1039336. PubMed ID: 36389163
[TBL] [Abstract][Full Text] [Related]
2. Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans.
Cheon SM; Jang I; Lee MH; Kim DK; Jeon H; Cha DS
Pharm Biol; 2017 Dec; 55(1):481-486. PubMed ID: 27937005
[TBL] [Abstract][Full Text] [Related]
3. Neurorescue Effects of Frondoside A and Ginsenoside Rg3 in
Chalorak P; Sanguanphun T; Limboonreung T; Meemon K
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443430
[TBL] [Abstract][Full Text] [Related]
4. Holothuria scabra extracts exhibit anti-Parkinson potential in C. elegans: A model for anti-Parkinson testing.
Chalorak P; Jattujan P; Nobsathian S; Poomtong T; Sobhon P; Meemon K
Nutr Neurosci; 2018 Jul; 21(6):427-438. PubMed ID: 28276260
[TBL] [Abstract][Full Text] [Related]
5. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson's disease genes.
Berkowitz LA; Hamamichi S; Knight AL; Harrington AJ; Caldwell GA; Caldwell KA
J Vis Exp; 2008 Jul; (17):. PubMed ID: 19066512
[TBL] [Abstract][Full Text] [Related]
6. MANF protects dopamine neurons and locomotion defects from a human α-synuclein induced Parkinson's disease model in C. elegans by regulating ER stress and autophagy pathways.
Zhang Z; Shen Y; Luo H; Zhang F; Peng D; Jing L; Wu Y; Xia X; Song Y; Li W; Jin L
Exp Neurol; 2018 Oct; 308():59-71. PubMed ID: 29959908
[TBL] [Abstract][Full Text] [Related]
7. Acetylcorynoline attenuates dopaminergic neuron degeneration and α-synuclein aggregation in animal models of Parkinson's disease.
Fu RH; Wang YC; Chen CS; Tsai RT; Liu SP; Chang WL; Lin HL; Lu CH; Wei JR; Wang ZW; Shyu WC; Lin SZ
Neuropharmacology; 2014 Jul; 82():108-20. PubMed ID: 23973292
[TBL] [Abstract][Full Text] [Related]
8. n-butylidenephthalide protects against dopaminergic neuron degeneration and α-synuclein accumulation in Caenorhabditis elegans models of Parkinson's disease.
Fu RH; Harn HJ; Liu SP; Chen CS; Chang WL; Chen YM; Huang JE; Li RJ; Tsai SY; Hung HS; Shyu WC; Lin SZ; Wang YC
PLoS One; 2014; 9(1):e85305. PubMed ID: 24416384
[TBL] [Abstract][Full Text] [Related]
9. Carpesii fructus extract exhibits neuroprotective effects in cellular and Caenorhabditis elegans models of Parkinson's disease.
Zhu FD; Wang BD; Qin DL; Su XH; Yu L; Wu JM; Law BY; Guo MS; Yu CL; Zhou XG; Wu AG
CNS Neurosci Ther; 2024 Apr; 30(4):e14515. PubMed ID: 37905594
[TBL] [Abstract][Full Text] [Related]
10. Anti-Parkinson activity of bioactive substances extracted from Holothuria leucospilota.
Malaiwong N; Chalorak P; Jattujan P; Manohong P; Niamnont N; Suphamungmee W; Sobhon P; Meemon K
Biomed Pharmacother; 2019 Jan; 109():1967-1977. PubMed ID: 30551452
[TBL] [Abstract][Full Text] [Related]
11. Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro.
Hsu YL; Hung HS; Tsai CW; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ; Fu RH
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638579
[TBL] [Abstract][Full Text] [Related]
12. Rose essential oil diminishes dopaminergic neuron degenerations and reduces α-synuclein aggregation in Caenorhabditis elegans models of Parkinson's disease.
Muhammad F; Liu Y; Wang N; Zhao L; Zhou Y; Yang H; Li H
Phytother Res; 2023 Jul; 37(7):2877-2893. PubMed ID: 36920348
[TBL] [Abstract][Full Text] [Related]
13. Alpha-linolenic acid suppresses dopaminergic neurodegeneration induced by 6-OHDA in C. elegans.
Shashikumar S; Pradeep H; Chinnu S; Rajini PS; Rajanikant GK
Physiol Behav; 2015 Nov; 151():563-9. PubMed ID: 26300470
[TBL] [Abstract][Full Text] [Related]
14. Chlorogenic acid delays the progression of Parkinson's disease via autophagy induction in
He CL; Tang Y; Wu JM; Long T; Yu L; Teng JF; Qiu WQ; Pan R; Yu CL; Qin DL; Wu AG; Zhou XG
Nutr Neurosci; 2023 Jan; 26(1):11-24. PubMed ID: 34927571
[TBL] [Abstract][Full Text] [Related]
15. Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson's disease.
Jadiya P; Khan A; Sammi SR; Kaur S; Mir SS; Nazir A
Biochem Biophys Res Commun; 2011 Oct; 413(4):605-10. PubMed ID: 21925152
[TBL] [Abstract][Full Text] [Related]
16. Potential Therapeutic Effects of Policosanol from Insect Wax on Caenorhabditis elegans Models of Parkinson's Disease.
Ma C; Feng Y; Li X; Sun L; He Z; Gan J; He M; Zhang X; Chen X
J Neuroimmune Pharmacol; 2023 Jun; 18(1-2):127-144. PubMed ID: 36637699
[TBL] [Abstract][Full Text] [Related]
17. Anti-Parkinson Effects of
Sanguanphun T; Promtang S; Sornkaew N; Niamnont N; Sobhon P; Meemon K
Mar Drugs; 2023 Feb; 21(3):. PubMed ID: 36976190
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of cannabidiol on dopaminergic neurodegeneration and α-synuclein accumulation in C. elegans models of Parkinson's disease.
Muhammad F; Liu Y; Wang N; Zhao L; Zhou Y; Yang H; Li H
Neurotoxicology; 2022 Dec; 93():128-139. PubMed ID: 36108815
[TBL] [Abstract][Full Text] [Related]
19. N-γ-(L-glutamyl)-L-selenomethionine shows neuroprotective effects against Parkinson's disease associated with SKN-1/Nrf2 and TRXR-1 in Caenorhabditis elegans.
Chang CH; Wei CC; Ho CT; Liao VH
Phytomedicine; 2021 Nov; 92():153733. PubMed ID: 34537465
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of damaurone D in a C. elegans model of Parkinson's disease.
Lee SH; Han YT; Cha DS
Neurosci Lett; 2021 Mar; 747():135623. PubMed ID: 33482307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
